Titlebook: Managing Gastrointestinal Complications of Diabetes; Joseph Sellin Book 2017 Springer International Publishing AG 2017 Diabetes.Type 2 dia

出租

書目名稱Managing Gastrointestinal Complications of Diabetes影響因子(影響力)




書目名稱Managing Gastrointestinal Complications of Diabetes影響因子(影響力)學(xué)科排名




書目名稱Managing Gastrointestinal Complications of Diabetes網(wǎng)絡(luò)公開度




書目名稱Managing Gastrointestinal Complications of Diabetes網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Managing Gastrointestinal Complications of Diabetes被引頻次




書目名稱Managing Gastrointestinal Complications of Diabetes被引頻次學(xué)科排名




書目名稱Managing Gastrointestinal Complications of Diabetes年度引用




書目名稱Managing Gastrointestinal Complications of Diabetes年度引用學(xué)科排名




書目名稱Managing Gastrointestinal Complications of Diabetes讀者反饋




書目名稱Managing Gastrointestinal Complications of Diabetes讀者反饋學(xué)科排名

Foolproof

defile

o 75% of patients visiting diabetes clinics report significant gastrointestinal symptoms. Includes guidelines for complication prevention, treatment, and long-term disease management..978-3-319-48661-1978-3-319-48662-8

Ethics

Book 2017cise format provides evidence-based content with a targeted emphasis on diagnosis,?as up to 75% of patients visiting diabetes clinics report significant gastrointestinal symptoms. Includes guidelines for complication prevention, treatment, and long-term disease management..

匍匐前進(jìn)

Small Intestine and Colon Complications in Patients with Diabetes,entral role in their pathogenesis. Limited familiarity with these conditions associated with DM leads to delay in their recognition and appropriate management. In this chapter, the effects of DM on the small and large intestine, as well as the associated gastrointestinal problems, are discussed.

ATRIA

Nonalcoholic Fatty Liver Disease, the absence of secondary causes of hepatic steatosis. NAFLD is a spectrum of disease that ranges from steatosis (hepatic fat without significant hepatocellular injury) to nonalcoholic steatohepatitis (NASH; hepatic fat with hepatocellular injury) to advanced fibrosis and cirrhosis.

補(bǔ)充

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma,hepatitis (NASH). Patients with NAFLD, especially NASH, are at risk for developing cirrhosis and its associated complications, including hepatocellular carcinoma (HCC). With the increasing prevalence of NAFLD closely linked to the growing epidemics of diabetes mellitus and obesity, NAFLD-related HCC is expected to rise.

Headstrong

Onerous

流行